Posts by: Alejandra Viviescas, PhD

Alejandra Viviescas, PhD

Alejandra has a PhD in Genetics from São Paulo State University (UNESP) and is currently working as a scientific writer, editor, and translator. As a writer for BioNews, she is fulfilling her passion for making scientific data easily available and understandable to the general public. Aside from her work with BioNews, she also works as a language editor for non-English speaking authors and is an author of science books for kids.

June 11, 2019June 11, 2019

Potential One-time Gene Therapy for Parkinson’s Linked to GBA Mutations to Enter Clinical Trial

News

A potential gene therapy for Parkinson’s disease associated with mutations in the GBA1 gene, PR001, will move into clinical testing in patients after the U.S. Food and Drug Administration (FDA) ... Read more

May 30, 2019August 2, 2019

Vitamin B12 May Protect Nerve Cells From Alpha-synuclein Clumps, Study Suggests

News

Vitamin B12 can prevent the formation of and destroy alpha-synuclein aggregates in the brain, lowering their toxicity and potentially helping to alleviate Parkinson’s disease, according to a study. The study, ... Read more

May 20, 2019June 27, 2019

Gocovri Leads to Steady ‘On’ States in Parkinson’s Patients, Phase 3 Pooled Data Suggest

News

Gocovri (amantadine) can effectively reduce the number and duration of “off” periods and dyskinesia (uncontrolled movement) episodes in Parkinson’s patients under long-term levodopa treatment, leading to a good steady “on” ... Read more

April 24, 2019June 3, 2019

Trace Amines Potential Biomarkers for Early Parkinson’s and Disease Progression, Study Suggests

News

Trace amines, the product of the metabolism of specific amino acids, could indicate changes that occur early during Parkinson’s disease and may serve as early-stage and disease progression biomarkers, a study ... Read more

April 1, 2019

High-frequency Brain Stimulation Is Superior for Parkinson’s Patients, Study Suggests

News

Repetitive transcranial magnetic stimulation (rTMS), given at high or low frequency, effectively reduces motor symptoms in Parkinson’s disease patients, but the effects of high-frequency rTMS are superior and last longer, a ... Read more

February 21, 2019February 22, 2019

Stem Cell Transplants Could Significantly Improve Parkinson’s Treatment, Study Suggests

News

Cell replacement therapies in which dopamine-producing stem cells are transplanted into Parkinson’s disease patients could improve motor symptoms, reducing or eliminating the need for dopaminergic medicines, a study suggests. The study, “Repairing the ... Read more

February 8, 2019February 14, 2019

New Diagnostics for PD Might Allow Early Diagnosis, Prevention

News

A new way of diagnosing Parkinson’s disease based on manifestations that appear decades before motor symptoms — the current hallmarks for diagnosis — might allow early diagnosis and even prevention. The ... Read more